Log In
BCIQ
Print this Print this
 

Lymfactin (AdVEGF-C)

  Manage Alerts
Collapse Summary General Information
Company Herantis Pharma plc
DescriptionAdenoviral vector expressing VEGF-C
Molecular Target Vascular endothelial growth factor C (VEGF-C)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat secondary lymphedema
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today